Rajeev A. Modi - 01 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President U.S. Pet Health and Global Digital Transformation
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for Rajeev A. Modi
Issuer symbol
ELAN
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 19:55:58 UTC
Previous filing
09 Sep 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +23,313 +54% $0.000000 66,355 01 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +53,246 $0.000000 53,246 01 Mar 2023 Common Stock 53,246 $11.26 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
F2 Includes 1,885 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan between September 30, 2022 and December 30, 2022.
F3 Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation